title: Palmar bullous blistering induced by erlotinib.
authors.affiliation: Department of Oncology, Oslo University Hospital-Radiumhospitalet, Oslo, Norway. arne.berg@oslo-universitetssykehus.no
authors.forename: Arne
authors.initials: A
authors.lastname: Berg
authors.forename: Odd Terje
authors.initials: OT
authors.lastname: Brustugun
authors.forename: Marius
authors.initials: M
authors.lastname: Lund-Iversen
authors.forename: Åslaug
authors.initials: Å
authors.lastname: Helland
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D001768:Blister / Q000139:chemically induced* / Q000188:drug therapy; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics; D000069347:Erlotinib Hydrochloride; D005260:Female; D006229:Hand Dermatoses / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008875:Middle Aged; D009154:Mutation / Q000235:genetics; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011799:Quinazolines / Q000009:adverse effects*; D016896:Treatment Outcome
chemical_list: D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; C512478:EGFR protein, human; D066246:ErbB Receptors